|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Due from related party | ||||||||||||
| Deferred offering costs | ||||||||||||
| Current assets | ||||||||||||
| Cash | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Inventory - current | ||||||||||||
| Prepaid expenses | ||||||||||||
| Accounts receivable | ||||||||||||
| Supplier advances | ||||||||||||
| Other receivables | ||||||||||||
| Total current assets | ||||||||||||
| Cash held in Trust Account | ||||||||||||
| Investments held in Trust Account | ||||||||||||
| Long-term inventory | ||||||||||||
| Property, plant, and equipment, net | ||||||||||||
| Operating lease right-of-use asset | ||||||||||||
| Intangible asset, net | ||||||||||||
| Deposits | ||||||||||||
| Total assets | ||||||||||||
| Accrued offering costs | ||||||||||||
| Promissory note - related party | ||||||||||||
| Current liabilities | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued expenses | ||||||||||||
| Promissory note - related party | ||||||||||||
| Non redemptions agreement liabilities | ||||||||||||
| Non-redemption agreements liabilities | ||||||||||||
| Accrued underwriting commission | ||||||||||||
| Deferred underwriting commission | ||||||||||||
| Seller note payable - current | ||||||||||||
| Operating lease liabilities - current | ||||||||||||
| Other payables | ||||||||||||
| Short term convertible notes | ||||||||||||
| Short term debt | ||||||||||||
| Related party payables - current | ||||||||||||
| Total current liabilities | ||||||||||||
| Deferred underwriting commissions | ||||||||||||
| Forward purchase options liabilities | ||||||||||||
| Forward purchase options liabilities | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Non-current liabilities | ||||||||||||
| Accrual for contingent liabilities | ||||||||||||
| Operating lease liabilities, net of current | ||||||||||||
| Related party payables | ||||||||||||
| Total liabilities | ||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 2,119,553 and 4,642,030 shares issued and outstanding at redemption value of approximately $10.54 and $10.16 per share as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 2,119,553 and 4,642,030 shares issued and outstanding at redemption value of approximately $10.54 and $10.16 per share as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Shareholders' deficit: | ||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022 | ||||||||||||
| Common stock; par value $0.0001, 300,000,000 shares authorized, 57,866,830 issued and outstanding at March 31, 2024 and December 31, 2023; Common stock; par value $0.0001, 70,000,000 shares authorized; Preferred stock 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2024 and December 31, 2023 | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total common stock; par value $0.0001, 300,000,000 shares authorized, 57,866,830 issued and outstanding at March 31, 2024 and December 31, 2023; Common stock; par value $0.0001, 70,000,000 shares authorized; Preferred stock 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2024 and December 31, 2023 | ||||||||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,666,667 and 6,666,667 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Additional paid-in-capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total shareholders' deficit | ||||||||||||
| Total liabilities and shareholders' deficit |
Loading...